These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 21591024)
21. MDM2 SNP309 accelerates breast and ovarian carcinogenesis in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent. Yarden RI; Friedman E; Metsuyanim S; Olender T; Ben-Asher E; Papa MZ Breast Cancer Res Treat; 2008 Oct; 111(3):497-504. PubMed ID: 18026875 [TBL] [Abstract][Full Text] [Related]
22. Mammography screening and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a prospective study. Giannakeas V; Lubinski J; Gronwald J; Moller P; Armel S; Lynch HT; Foulkes WD; Kim-Sing C; Singer C; Neuhausen SL; Friedman E; Tung N; Senter L; Sun P; Narod SA Breast Cancer Res Treat; 2014 Aug; 147(1):113-8. PubMed ID: 25082516 [TBL] [Abstract][Full Text] [Related]
23. Comparing the frequency of common genetic variants and haplotypes between carriers and non-carriers of BRCA1 and BRCA2 deleterious mutations in Australian women diagnosed with breast cancer before 40 years of age. Turkovic L; Gurrin LC; Bahlo M; Dite GS; Southey MC; Hopper JL BMC Cancer; 2010 Sep; 10():466. PubMed ID: 20807450 [TBL] [Abstract][Full Text] [Related]
25. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families. Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231 [TBL] [Abstract][Full Text] [Related]
26. Polymorphic repeat length in the AIB1 gene and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a meta-analysis of observational studies. Bianco A; Quaresima B; Pileggi C; Faniello MC; De Lorenzo C; Costanzo F; Pavia M PLoS One; 2013; 8(3):e57781. PubMed ID: 23483928 [TBL] [Abstract][Full Text] [Related]
27. Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk. Gaudet MM; Kuchenbaecker KB; Vijai J; Klein RJ; Kirchhoff T; McGuffog L; Barrowdale D; Dunning AM; Lee A; Dennis J; Healey S; Dicks E; Soucy P; Sinilnikova OM; Pankratz VS; Wang X; Eldridge RC; Tessier DC; Vincent D; Bacot F; Hogervorst FB; Peock S; Stoppa-Lyonnet D; ; Peterlongo P; Schmutzler RK; Nathanson KL; Piedmonte M; Singer CF; Thomassen M; ; Hansen Tv; Neuhausen SL; Blanco I; Greene MH; Garber J; Weitzel JN; Andrulis IL; Goldgar DE; D'Andrea E; Caldes T; Nevanlinna H; Osorio A; van Rensburg EJ; Arason A; Rennert G; van den Ouweland AM; van der Hout AH; Kets CM; Aalfs CM; Wijnen JT; Ausems MG; ; ; Frost D; Ellis S; Fineberg E; Platte R; Evans DG; Jacobs C; Adlard J; Tischkowitz M; Porteous ME; Damiola F; ; Golmard L; Barjhoux L; Longy M; Belotti M; Ferrer SF; Mazoyer S; Spurdle AB; Manoukian S; Barile M; Genuardi M; Arnold N; Meindl A; Sutter C; Wappenschmidt B; Domchek SM; Pfeiler G; Friedman E; Jensen UB; Robson M; Shah S; Lazaro C; Mai PL; Benitez J; Southey MC; Schmidt MK; Fasching PA; Peto J; Humphreys MK; Wang Q; Michailidou K; Sawyer EJ; Burwinkel B; Guénel P; Bojesen SE; Milne RL; Brenner H; Lochmann M; ; Aittomäki K; Dörk T; Margolin S; Mannermaa A; Lambrechts D; Chang-Claude J; Radice P; Giles GG; Haiman CA; Winqvist R; Devillee P; García-Closas M; Schoof N; Hooning MJ; Cox A; Pharoah PD; Jakubowska A; Orr N; González-Neira A; Pita G; Alonso MR; Hall P; Couch FJ; Simard J; Altshuler D; Easton DF; Chenevix-Trench G; Antoniou AC; Offit K PLoS Genet; 2013; 9(3):e1003173. PubMed ID: 23544012 [TBL] [Abstract][Full Text] [Related]
28. Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study report. Bernstein JL; Thomas DC; Shore RE; Robson M; Boice JD; Stovall M; Andersson M; Bernstein L; Malone KE; Reiner AS; Lynch CF; Capanu M; Smith SA; Tellhed L; Teraoka SN; Begg CB; Olsen JH; Mellemkjaer L; Liang X; Diep AT; Borg A; Concannon P; Haile RW; Eur J Cancer; 2013 Sep; 49(14):2979-85. PubMed ID: 23706288 [TBL] [Abstract][Full Text] [Related]
29. Impact of Age at Primary Breast Cancer on Contralateral Breast Cancer Risk in BRCA1/2 Mutation Carriers. van den Broek AJ; van 't Veer LJ; Hooning MJ; Cornelissen S; Broeks A; Rutgers EJ; Smit VT; Cornelisse CJ; van Beek M; Janssen-Heijnen ML; Seynaeve C; Westenend PJ; Jobsen JJ; Siesling S; Tollenaar RA; van Leeuwen FE; Schmidt MK J Clin Oncol; 2016 Feb; 34(5):409-18. PubMed ID: 26700119 [TBL] [Abstract][Full Text] [Related]
30. The risk of breast cancer in BRCA1 and BRCA2 mutation carriers without a first-degree relative with breast cancer. Metcalfe KA; Lubinski J; Gronwald J; Huzarski T; McCuaig J; Lynch HT; Karlan B; Foulkes WD; Singer CF; Neuhausen SL; Senter L; Eisen A; Sun P; Narod SA; Clin Genet; 2018 May; 93(5):1063-1068. PubMed ID: 29206279 [TBL] [Abstract][Full Text] [Related]
31. Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study. McLaughlin JR; Risch HA; Lubinski J; Moller P; Ghadirian P; Lynch H; Karlan B; Fishman D; Rosen B; Neuhausen SL; Offit K; Kauff N; Domchek S; Tung N; Friedman E; Foulkes W; Sun P; Narod SA; Lancet Oncol; 2007 Jan; 8(1):26-34. PubMed ID: 17196508 [TBL] [Abstract][Full Text] [Related]
32. miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers. Vos S; Vesuna F; Raman V; van Diest PJ; van der Groep P Oncotarget; 2015 Oct; 6(31):32115-37. PubMed ID: 26378051 [TBL] [Abstract][Full Text] [Related]
33. Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A. Mote PA; Leary JA; Avery KA; Sandelin K; Chenevix-Trench G; Kirk JA; Clarke CL; Genes Chromosomes Cancer; 2004 Mar; 39(3):236-48. PubMed ID: 14732925 [TBL] [Abstract][Full Text] [Related]
35. Vitamin D Receptor Gene Polymorphism: Association with Susceptibility to Early-Onset Breast Cancer in Iranian, BRCA1/2-Mutation Carrier and non-carrier Patients. Shahabi A; Alipour M; Safiri H; Tavakol P; Alizadeh M; Milad Hashemi S; Shahabi M; Halimi M Pathol Oncol Res; 2018 Jul; 24(3):601-607. PubMed ID: 28780723 [TBL] [Abstract][Full Text] [Related]
36. Phenocopy breast cancer rates in Israeli BRCA1 BRCA2 mutation carrier families: is the risk increased in non-carriers? Bernholtz S; Laitman Y; Kaufman B; Shimon-Paluch S; Friedman E Breast Cancer Res Treat; 2012 Apr; 132(2):669-73. PubMed ID: 22113258 [TBL] [Abstract][Full Text] [Related]
37. Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Kotsopoulos J; Lubinski J; Salmena L; Lynch HT; Kim-Sing C; Foulkes WD; Ghadirian P; Neuhausen SL; Demsky R; Tung N; Ainsworth P; Senter L; Eisen A; Eng C; Singer C; Ginsburg O; Blum J; Huzarski T; Poll A; Sun P; Narod SA; Breast Cancer Res; 2012 Mar; 14(2):R42. PubMed ID: 22405187 [TBL] [Abstract][Full Text] [Related]
38. Associations of Single Nucleotide Polymorphism in miR-146a Gene with Susceptibility to Breast Cancer in the Iranian Female. Siasi E; Solimani M Asian Pac J Cancer Prev; 2020 Jun; 21(6):1585-1593. PubMed ID: 32592352 [TBL] [Abstract][Full Text] [Related]
39. Hereditary breast and ovarian cancer: new genes, new treatments, new concepts. Meindl A; Ditsch N; Kast K; Rhiem K; Schmutzler RK Dtsch Arztebl Int; 2011 May; 108(19):323-30. PubMed ID: 21637635 [TBL] [Abstract][Full Text] [Related]
40. Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs. Li N; Rowley SM; Thompson ER; McInerny S; Devereux L; Amarasinghe KC; Zethoven M; Lupat R; Goode D; Li J; Trainer AH; Gorringe KL; James PA; Campbell IG Breast Cancer Res; 2018 Jan; 20(1):3. PubMed ID: 29316957 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]